Medience Co., Ltd. (KOSDAQ:014100)
South Korea
· Delayed Price · Currency is KRW 1,795.00
+58.00 (3.34%)
At close: Apr 28, 2026
Medience Revenue
In the year 2025, Medience had annual revenue of 48.77B KRW, down -0.44%. Medience had revenue of 10.67B in the quarter ending December 31, 2025, with 2.06% growth.
Revenue
48.77B
Revenue Growth
-0.44%
P/S Ratio
0.42
Revenue / Employee
225.78M
Employees
216
Market Cap
20.27B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 48.77B | -216.56M | -0.44% |
| Dec 31, 2024 | 48.99B | -17.04B | -25.80% |
| Dec 31, 2023 | 66.02B | -5.40B | -7.56% |
| Dec 31, 2022 | 71.42B | -102.69M | -0.14% |
| Dec 31, 2021 | 71.52B | -3.01B | -4.04% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Nord Mason | 21.26B |
| INNOGENE | 8.21B |
| Ha U Dong Chun | 1.89B |
| Csa Cosmic | 27.93B |
| Outin Futures | 42.39B |
| KMPHARMACEUTICAL | 15.99B |
| Bonne | 46.01B |
| SR biotek | 1.62B |